⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL733890 | 0.87 | — | — | |
| SCHEMBL15883181 | 0.82 | — | — | |
| SCHEMBL19105000 | 0.77 | — | — | |
| SCHEMBL769365 | 0.75 | — | — | |
| SCHEMBL385951 | 0.73 | — | — | |
| SCHEMBL12466298 | 0.71 | — | — | |
| SCHEMBL887785 | 0.71 | TSHR (0.30) | — | |
| SCHEMBL753358 | 0.71 | — | — | |
| SCHEMBL13467884 | 0.67 | — | — | |
| SCHEMBL5930 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 330 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118754922-B | Allyl-cyanoethyl nucleoside dimer, preparation method thereof and application thereof in oligonucleotide synthesis | 中国人民解放军军事科学院军事医学研究院 | 2025-06-24 | — | — | CN | claimed |
| CN-118754922-A | Allyl-cyanoethyl nucleoside dimer, preparation method thereof and application thereof in oligonucleotide synthesis | 中国人民解放军军事科学院军事医学研究院 | 2024-10-11 | — | — | CN | claimed |
| WO-2024031192-A1 | SMALL MOLECULE PHOSPHORAMIDITE DERIVATIVES AND USES THEREOF | UNIVERSITY OF ONTARIO INSTITUTE OF TECHNOLOGY (CA) | 2024-02-15 | — | — | WO | claimed |
| EP-3430022-A1 | COMPOUNDS AND METHODS FOR THE SYNTHESIS OF 5-(N-PROTECTED-TRYPTAMINOCARBOXYAMIDE)-2'-DEOXYURIDINE PHOSPHORAMIDATE FOR INCORPORATION INTO A NUCLEIC SEQUENCE | Somalogic, Inc. (US) | 2019-01-23 | — | — | EP | claimed |
| WO-2017160672-A1 | COMPOUNDS AND METHODS FOR THE SYNTHESIS OF 5-(N-PROTECTED-TRYPTAMINOCARBOXYAMIDE)-2'-DEOXYURIDINE PHOSPHORAMIDATE FOR INCORPORATION INTO A NUCLEIC SEQUENCE | SOMALOGIC, INC. (US) | 2017-09-21 | — | — | WO | claimed |
| EP-1409497-A2 | METHOD FOR PREPARATION OF LNA PHOSPHORAMIDITES | Santaris Pharma A/S (DK) | 2004-04-21 | — | — | EP | claimed |
| JP-2003520042-A | — | — | 2003-07-02 | — | — | JP | claimed |
| WO-2003006475-A2 | METHOD FOR PREPARATION OF LNA PHOSPHORAMIDITES | SANTARIS PHARMA A/S (DK) | 2003-01-23 | — | — | WO | claimed |
| EP-1250157-A1 | ANTISENSE MODULATION OF INDUCIBLE NITRIC OXIDE SYNTHASE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2002-10-23 | — | — | EP | claimed |
| WO-2001052902-A1 | ANTISENSE MODULATION OF INDUCIBLE NITRIC OXIDE SYNTHASE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2001-07-26 | — | — | WO | claimed |
| CN-122036787-A | Synthesis of cyclooctenamine linker and application of cyclooctenamine linker in coupled medicine | 苏州盛诺维生物科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-118754922-B | Allyl-cyanoethyl nucleoside dimer, preparation method thereof and application thereof in oligonucleotide synthesis | 中国人民解放军军事科学院军事医学研究院 | 2025-06-24 | — | — | CN | disclosed |
| CN-119156232-A | Antibody-drug conjugate precursors and synthetic intermediates thereof | ＵＢＥ株式会社 | 2024-12-17 | — | — | CN | disclosed |
| CN-119095625-A | Antibody-drug conjugates | ＵＢＥ株式会社 | 2024-12-06 | — | — | CN | disclosed |
| CN-118813612-A | Application of compound in RNAi (ribonucleic acid interference) medicament | 纳肽得(青岛)生物医药有限公司 | 2024-10-22 | — | — | CN | disclosed |
| WO-2000040595-A1 | ANTISENSE MODULATION OF NOVEL ANTI-APOPTOTIC BCL-2-RELATED PROTEINS | ISIS PHARMACEUTICALS, INC. (US) | 2000-07-13 | — | — | WO | disclosed |
| WO-2000036148-A1 | ANTISENSE MODULATION OF SENTRIN EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000014098-A1 | METHODS FOR THE PREPARATION OF CONJUGATED OLIGOMERS | ISIS PHARMACEUTICALS, INC. (US) | 2000-03-16 | — | — | WO | disclosed |
| WO-1999049065-A1 | ANTISENSE MODULATION OF HUMAN MDM2 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 1999-09-30 | — | — | WO | disclosed |
| WO-1999040101-A1 | SYNTHETIC PROCESS FOR THE PREPARATION OF OLIGONUCLEOTIDES, NUCLEOSIDE SYNTHONS USED THEREIN, AND OLIGONUCLEOTIDES PREPARED THEREBY | ISIS PHARMACEUTICALS, INC. (US) | 1999-08-12 | — | — | WO | disclosed |